Page last updated: 2024-10-27

gabexate and Scleroderma, Systemic

gabexate has been researched along with Scleroderma, Systemic in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research Excerpts

ExcerptRelevanceReference
"This is the first case report of severe acute pancreatitis in the setting of overlap syndrome of SLE and SSc."1.33A case of severe acute pancreatitis, in overlap syndrome of systemic sclerosis and systemic lupus erythematosus, successfully treated with plasmapheresis. ( Hara, M; Kamatani, N; Koizumi, K; Okamoto, H; Suzuki, Y; Tateishi, M, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suzuki, Y1
Okamoto, H1
Koizumi, K1
Tateishi, M1
Hara, M1
Kamatani, N1

Other Studies

1 other study available for gabexate and Scleroderma, Systemic

ArticleYear
A case of severe acute pancreatitis, in overlap syndrome of systemic sclerosis and systemic lupus erythematosus, successfully treated with plasmapheresis.
    Modern rheumatology, 2006, Volume: 16, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Female; Gabexate; Humans; Lupus Erythematosus, Systemic; Methylpred

2006